Literature DB >> 26396462

Innovative Medicines Initiative (IMI) Case Study Analysis Reveals the True Added Value of Early-Phase Public-Private Partnerships (PPPs).

Hilde Stevens, Geertrui Van Overwalle, Bart Van Looy, Isabelle Huys.   

Abstract

Year:  2015        PMID: 26396462      PMCID: PMC4574745          DOI: 10.1089/blr.2015.29008.hs

Source DB:  PubMed          Journal:  Biotechnol Law Rep        ISSN: 0730-031X            Impact factor:   0.146


× No keyword cloud information.
  2 in total

1.  Intellectual property policies in early-phase research in public-private partnerships.

Authors:  Hilde Stevens; Geertrui Van Overwalle; Bart Van Looy; Isabelle Huys
Journal:  Nat Biotechnol       Date:  2016-05-06       Impact factor: 54.908

Review 2.  Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact.

Authors:  Remco L A de Vrueh; Daan J A Crommelin
Journal:  Pharm Res       Date:  2017-06-06       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.